ecancermedicalscience

Research

Impact of various prognostic factors on survival in glioblastoma: tertiary care institutional experience

12 May 2022
Swapna Jilla, Archana Prathipati, Bala Venkata Subramanian, Pranabandhu Das

Introduction: Glioblastoma is the most common malignant brain tumour in adults. Among all gliomas, it is the most aggressive type, with a high fatality rate, and according to the WHO classification, it is a grade IV tumour. As this tumour is well-known for its poor survival, an understanding of clinical and treatment-related prognostic factors can help in tailored treatment. The aim of this study was to know the impact of prognostic factors on survival in these cases.

Materials and methods: All glioblastoma patients treated in our hospital during 2010–2015 were included in the analysis. Cases were divided into different groups based on prognostic factors. Overall survival (OS) and disease-free survival (DFS) were calculated and compared among the different groups. Statistical analysis was carried out using SPSS software v20.

Results: One-year OS was 36.9% and 2-year OS was 10.8%. One-year DFS was 13.04%. On univariate analysis, age at presentation ≤45 years and adjuvant chemotherapy with six cycles or more temozolomide improved OS and DFS. Multivariate analysis retained the statistically significant positive impact of usage of adjuvant temozolomide chemotherapy of ≥six cycles on OS and DFS. The use of the anti-epileptic drug Levetiracetam had a statistically significant improvement of DFS.

Conclusion: Among various clinical and treatment-related prognostic factors evaluated in our study, younger age at presentation and addition of temozolomide chemotherapy to radiation showed improvement in OS and DFS. The use of the anti-epileptic drug Levetiracetam had an impact on DFS in glioblastoma patients.

Related Articles

Ronald Limón, Lucia Reynolds, Erick Rocha, Lucia Richter, Mario Gianella, Oscar Niño de Guzman, Gerson Mejía, José Nina, Wendy Rojas, Lijia Avilés, Iván Maldonado, Cristian Pacheco, Claudio Martín, Maria G Cervantes, Federico Bakal, Eduardo Cazap